Literature DB >> 4286707

Corticosteroids and corticotrophin in the treatment of Crohn's disease.

J H Jones, J E Lennard-Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4286707      PMCID： PMC1552340          DOI： 10.1136/gut.7.2.181

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  CROHN'S DISEASE.

Authors:  H EDWARDS
Journal:  J R Coll Surg Edinb       Date:  1964-01

2.  ILEO-CAECAL TUBERCULOSIS.

Authors:  J S HOWELL; P J KNAPTON
Journal:  Gut       Date:  1964-12       Impact factor: 23.059

3.  CROHN'S DISEASE OF THE LARGE INTESTINE.

Authors:  H E LOCKHART-MUMMERY; B C MORSON
Journal:  Gut       Date:  1964-12       Impact factor: 23.059

4.  ILEO-CAECAL GRANULOMATA.

Authors:  F D LEE; A D ROY
Journal:  Gut       Date:  1964-12       Impact factor: 23.059
  4 in total
  24 in total

Review 1.  Steroid use in Crohn's disease.

Authors:  Stephan R Vavricka; Alain M Schoepfer; Michael Scharl; Gerhard Rogler
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

Review 2.  Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.

Authors:  Ersilia M DeFilippis; Randy Longman; Michael Harbus; Kyle Dannenberg; Ellen J Scherl
Journal:  Curr Gastroenterol Rep       Date:  2016-03

3.  Corticosteroid or corticotrophin therapy in Crohn's disease (regional enteritis).

Authors:  W T Cooke; J F Fielding
Journal:  Gut       Date:  1970-11       Impact factor: 23.059

4.  Regional enteritis and entero-colitis: a study of 74 patients over 15 years.

Authors:  C B Brill; S F Klein; A E Kark
Journal:  Ann Surg       Date:  1969-11       Impact factor: 12.969

5.  Crohn's disease: natural history and treatment.

Authors:  J E Lennard-Jones
Journal:  Postgrad Med J       Date:  1968-09       Impact factor: 2.401

6.  Medical aspects of Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Proc R Soc Med       Date:  1968-01

7.  Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.

Authors:  T Andus; V Gross; I Caesar; H J Schulz; H Lochs; W D Strohm; M Gierend; A Weber; K Ewe; J Schölmerich
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

8.  Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease.

Authors:  H Hirakawa; Y Fukuda; N Tanida; M Hosomi; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1993-06

9.  Low dose steroids and clinical relapse in Crohn's disease: a controlled trial.

Authors:  R C Smith; J Rhodes; R V Heatley; L E Hughes; D L Crosby; B I Rees; H Jones; K T Evans; B W Lawrie
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

Review 10.  Anti-TNF strategies in stenosing and fistulizing Crohn's disease.

Authors:  Martin H Holtmann; Markus F Neurath
Journal:  Int J Colorectal Dis       Date:  2004-09-30       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.